Reuters logo
BRIEF-Crossject H1 net loss widens to ‍3.4​ million euros
September 21, 2017 / 4:44 PM / 3 months ago

BRIEF-Crossject H1 net loss widens to ‍3.4​ million euros

Sept 21 (Reuters) - CROSSJECT SA:

* H1 NET LOSS EUR ‍3.4​ MILLION VERSUS LOSS OF EUR 2.8 MILLION YEAR AGO

* H1 OPERATING LOSS EUR ‍​ 4.3 MILLION VERSUS LOSS OF EUR 2.8 MILLION YEAR AGO

* CASH POSITION AT JUNE 30 EUR 6.1‍​ MILLION

* TO BE ABLE TO RELY ON ADDITIONAL CASH ESTIMATED AT € 5.9 MILLION UNTIL DEC., 31 2018‍​

* CLINICAL STUDIES FOR ZENEO SUMATRIPTAN, ZENEO ADRENALINE AND ZENEO MIDAZOLAM SHOULD BE COMPLETED IN 2018​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below